We introduce a global feature extraction method specifically designed to preprocess magnetic resonance spectra of biomedical origin. Such preprocessing is essential for the accurate and reliable classification of diseases or disease stages manifest in the spectra. The new method is genetic algorithm-guided. It is compared with our enhanced version of the standard forward selection algorithm. Both seek and select optimal spectral subregions. These subregions necessarily retain spectral information, thus aiding the eventual identification of the biochemistry of disease presence and progression. The power of the methods is demonstrated on two biomedical examples: the discrimination between meningioma and astrocytoma in brain tissue biopsies, and the classification of colorectal biopsies into normal and tumour classes. Both preprocessing methods lead to classification accuracies over 97% for the two examples.